The multimodal featuresof our approach was demonstrated by bioorthogonal fluorescent labelingof PD-L1-expressing cancer cells and by programming PD-L1-selectivecell death through click-to-release activation of cytotoxic agents,using the same molecular construct. This evidence concerns the gene CD274 and cancer.